Parasitology Mycology, Virology, Immunology
Parasitology Mycology, Virology, Immunology
Parasitology Mycology, Virology, Immunology
Introduction
Parasites are organisms that obtain food and shelter by living on or within another organism.
The parasite derives all benefits from association and the host may either not be harmed or
may suffer the consequences of this association, a parasite disease. The parasite is termed
obligate when it can live only in association with a host or it is classified as facultative when it
can live both in or on a host as well as in a free form. Parasites which live inside the body are
termed endoparasites whereas those which exist on the body surface are called ectoparasites.
Parasites that cause harm to the host are pathogenic parasites while those that benefit from
the host without causing it any harm are known as commensals.
In this section, we shall investigate a variety of parasites of medical importance ranging in size
from protozoans such as the amebae and trypanosomes to multicellular worms and flukes. We
shall also look at some arthropod parasites. Diseases caused by these organisms include amebic
dysentary, sleeping sickness, malaria, river-blindness and elephantiasis.
tapeworm
Parasitology
Fields
The study of these diverse organisms means that the subject is often broken up into
simpler, more focused units, which use common techniques, even if they are not studying the
same organisms or diseases. Much research in parasitology falls somewhere between two or
more of these definitions. In general, the study of prokaryotes fall under the field of
bacteriology rather than parasitology.
1. Medical parasitology
One of the largest fields in parasitology,
medical parasitology is the subject which deals
with the parasites that infect man, the diseases
caused by them, clinical picture and the response
generated by man against them. It's also concerned
with the various methods of their diagnosis,
treatment and finally their prevention & control. A
parasite is an organism that live on or within
another organism called the host.
Medical parasitology can involve drug development, epidemiological studies and study of
zoonoses.
Parasitology
2. Veterinary parasitology
The study of parasites that cause economic
losses in agriculture or aquaculture operations, or
which infect companion animals. Examples of
species studied are:
Gyrodactylus salaris, a monogenean parasite of salmon, which can wipe out populations which
are not resistant.
3. Structural parasitology
This is the study of structures of proteins
from parasites. Determination of parasitic protein
structures may help to better understand how
these proteins function differently from
homologous proteins in humans. In addition,
protein structures may inform the process of drug
discovery.
4. Quantitative parasitology
Parasites exhibit an aggregated distribution among host individuals, thus the majority of
parasites live in the minority of hosts. This feature forces parasitologists to use advanced
biostatistical methodologies.
Parasitology
5. Parasite ecology
Parasites can provide information about
host population ecology. In fisheries biology, for
example, parasite communities can be used to
distinguish distinct populations of the same fish
species co-inhabiting a region. Additionally,
parasites possess a variety of specialized traits
and life-history strategies that enable them to
colonize hosts. Understanding these aspects of
parasite ecology, of interest in their own right, can illuminate parasite-avoidance strategies
employed by hosts.
Mycology (from the Greek μύκης, mukēs, meaning "fungus") is the branch of biology
concerned with the study of fungi, including their genetic and biochemical properties, their
taxonomy and their use to humans as a source for tinder, medicinals (e.g., penicillin), food (e.g.,
beer, wine, cheese, edible mushrooms) and entheogens, as well as their dangers, such as
poisoning or infection.
From mycology arose the field of phytopathology, the study of plant diseases, and the two
disciplines remain closely related because the vast majority of plant pathogens are fungi. A
biologist who studies mycology is called a mycologist.
Historically, mycology was a branch of botany (fungi are evolutionarily more closely related to
animals than to plants but this was not recognized until a few decades ago). Pioneer
mycologists included Elias Magnus Fries, Christian Hendrik Persoon, Anton de Bary and Lewis
David von Schweinitz.
Many fungi produce toxins, antibiotics and other secondary metabolites. For example the
cosmopolitan (worldwide) genus Fusarium and their toxins associated with fatal outbreaks of
alimentary toxic aleukia in humans were extensively studied by Abraham Joffe.
Fungi are fundamental for life on earth in their roles as symbionts, e.g. in the form of
mycorrhizae, insect symbionts and lichens, potency in breaking down complex organic
biomolecules such as lignin, the more durable component of wood, and by playing a role in
xenobiotics, a critical step in the global carbon cycle.
Hyaline Moulds
Mycology
Continuation...
Fungi and other organisms traditionally recognized as fungi, such as oomycetes and
myxomycetes (slime molds), often are economically and socially important as some cause
diseases of animals (such as histoplasmosis) as well as plants (such as Dutch elm disease and
Rice blast).
Field meetings to find interesting species of fungi are known as 'forays', after the first such
meeting organized by the Woolhope Naturalists' Field Club in 1868 and entitled "a foray among
the fungi."
Some fungi can cause disease in humans or other organisms. The study of pathogenic fungi is
referred to as medical mycology
Fungi are eukaryotic organisms that do not contain chlorophyll, but have cell walls, filamentous
structures, and produce spores. These organisms grow as saprophytes and decompose dead
organic matter. There are between 100,000 to 200,000 species depending on how they are
classified. About 300 species are presently known to be pathogenic for man.
2. Mycotoxicoses - poisoning of man and animals by feeds and food products contaminated by
fungi which produce toxins from the grain substrate.
4. Infection
History
Humans probably started collecting mushrooms as food in Prehistoric times.
Mushrooms were first written about in the works of Euripides (480-406 B.C.). The Greek
philosopher Theophrastos of Eressos (371-288 B.C.) was perhaps the first to try to
systematically classify plants; mushrooms were considered to be plants that were missing
certain organs. It was later Pliny the elder (23–79 A.D.), who wrote about truffles in his
encyclopedia Naturalis historia.
Mycology
Continuation...
The Middle Ages saw little advancement in the body of knowledge about fungi. Rather, the
invention of the printing press allowed some authors to disseminate superstitions and
misconceptions about the fungi that had been perpetuated by the classical authors.
“ Fungi and truffles are neither herbs, nor roots, nor flowers, nor seeds, but merely the
superfluous moisture or earth, of trees, or rotten wood, and of other rotting things. This is plain
from the fact that all fungi and truffles, especially those that are used for eating, grow most
commonly in thundery and wet weather. ”
The start of the modern age of mycology begins with Pier Antonio Micheli's 1737
publication of Nova plantarum genera. Published in Florence, this seminal work laid the
foundations for the systematic classification of grasses, mosses and fungi. The term mycology
and the complimentary mycologist were first used in 1836 by M.J. Berkeley.
Medicinal Mycology
For centuries, certain mushro oms have
been documented as a folk medicine in China,
Japan, and Russia. Although the use of
mushrooms in folk medicine is largely centered on
the Asian continent, people in other parts of the
world like the Middle East, Poland and Belarus
have been documented using mushrooms for
medicinal purposes. Certain mushrooms,
especially polypores like Reishi were thought to be able to benefit a wide variety of health
ailments. Medicinal mushroom research in the United States is currently active, with studies
taking place at City of Hope National Medical Center, as well as the Memorial Sloan–Kettering
Cancer Center.
Current research focuses on mushroom's that may have hypoglycemic activity, anti-cancer
activity, anti-pathogenic activity, and immune system enhancing activity. Recent research has
found that the oyster mushroom naturally contains the cholesterol drug lovastatin, mushrooms
produce large amounts of vitamin D when exposed to UV light, and that certain fungi may be a
future source of taxol. To date, penicillin, lovastatin, ciclosporin, griseofulvin, cephalosporin,
ergometrine, and statins are the most famous pharmaceuticals which have been isolated from
the fungi kingdom.
Virology
Introduction
The most useful and most widely used classification system distinguishes viruses according to
the type of nucleic acid they use as genetic material and the viral replication method they
employ to coax host cells into producing more viruses:
DNA viruses (divided into double-stranded DNA viruses and the much less common single-
stranded DNA viruses),
RNA viruses (divided into positive-sense single-stranded RNA viruses, negative-sense single-
stranded RNA viruses and the much less common double-stranded RNA viruses),
Virology
Continuation...
(proteins that can exist in a pathological conformation that induces other prion molecules to
assume that same conformation).
The latest report by the International Committee on Taxonomy of Viruses (2005) lists 5450
viruses, organized in over 2,000 species, 287 genera, 73 families and 3 orders.
The taxa in virology are not necessarily monophyletic. In fact, the evolutionary relationships of
the various virus groups remain unclear, and three hypotheses regarding their origin exist:
Viruses arose from non-living matter, separately from and in parallel to other life forms,
possibly in the form of self-reproducing RNA ribozymes similar to viroids.
Viruses arose from earlier, more competent cellular life forms that became parasites to host
cells and subsequently lost most of their functionality; examples of such tiny parasitic
prokaryotes are Mycoplasma and Nanoarchaea.
Viruses arose as parts of the genome of cells, most likely transposons or plasmids, that acquired
the ability to "break free" from the host cell and infect other cells.
Of particular interest here is mimivirus, a giant virus that infects amoebae and carries much of
the molecular machinery traditionally associated with bacteria. Is it a simplified version of a
parasitic prokaryote, or did it originate as a simpler virus that acquired genes from its host?
The evolution of viruses, which often occurs in concert with the evolution of their hosts, is
studied in the field of viral evolution.
While viruses reproduce and evolve, they don't engage in metabolism and depend on a host
cell for reproduction. The often-debated question of whether they are alive or not is a matter of
definition that does not affect the biological reality of viruses.
Virology
Some viruses, known as oncoviruses, contribute to certain forms of cancer. The best studied
example is the association between Human papillomavirus and cervical cancer: it is now
acknowledged that almost all cases of cervical cancer are caused by certain strains of this
sexually transmitted virus. Another example is infection with hepatitis B and hepatitis C viruses,
which are associated with liver cancer.
Some subviral particles also cause disease: the transmissible spongiform encephalopathies,
which include Kuru, Creutzfeldt-Jakob disease and bovine spongiform encephalopathy ("mad
cow disease"), are caused by prions, and hepatitis D is due to a satellite virus.
The study of the manner in which viruses cause disease is viral pathogenesis. The degree to
which a virus causes disease is its virulence.
When the immune system of a vertebrate encounters a virus, it produces specific antibodies
which bind to the virus and mark it for destruction. The presence of these antibodies is often
used to determine whether a person has been exposed to a given virus in the past, with tests
such as ELISA. Vaccinations protect against viral diseases, in part, by eliciting the production of
antibodies. Specifically constructed monoclonal antibodies can also be used to detect the
presence of viruses, with a technique called fluorescence microscopy.
A second defense of vertebrates against viruses, cell-mediated immunity, involves immune cells
known as T cells: the body's cells constantly display short fragments of their proteins on the
cell's surface, and if a T cell recognizes a suspicious viral fragment there, the host cell is
destroyed and the virus-specific T-cells proliferate. This mechanism is jump-started by certain
vaccinations.
RNA interference, an important cellular mechanism found in plants, animals and many other
eukaryotes, most likely evolved as a defense against viruses.
Virology
Continuation...
Every lethal viral disease presents a paradox: killing its host is obviously of no benefit to the
virus, so how and why did it evolve to do so? Today it is believed that most viruses are relatively
benign in their natural hosts; the lethal viral diseases are explained as resulting from an
"accidental" jump of the virus from a species in which it is benign to a new one that is not
accustomed to it (see zoonosis). For example, serious influenza viruses probably have pigs or
birds as their natural host, and HIV is thought to derive from the benign non-human primate
virus SIV.
While it has been possible to prevent (certain) viral diseases by vaccination for a long time, the
development of antiviral drugs to treat viral diseases is a comparatively recent development.
The first such drug was interferon, a substance that is naturally produced by certain immune
cells when an infection is detected and stimulates other parts of the immune system.
Bacteriophages, the viruses which infect bacteria, can be relatively easily grown as viral
plaques on bacterial cultures. Bacteriophages occasionally move genetic material from one
bacterial cell to another in a process known as transduction, and this horizontal gene transfer is
one reason why they served as a major research tool in the early development of molecular
biology. The genetic code, the function of ribozymes, the first recombinant DNA and early
genetic libraries were all arrived at using bacteriophages. Certain genetic elements derived
from viruses, such as highly effective promoters, are commonly used in molecular biology
research today.
Growing animal viruses outside of the living host animal is more difficult. Classically, fertilized
chicken eggs have often been used, but cell cultures are increasingly employed for this purpose
today.
Virology
Continuation...
Since some viruses that infect eukaryotes need to transport their genetic material into the host
cell's nucleus, they are attractive tools for introducing new genes into the host (known as
transformation or transfection). Modified retroviruses are often used for this purpose, as they
integrate their genes into the host's chromosomes.
This approach of using viruses as gene vectors is being pursued in the gene therapy of genetic
diseases. An obvious problem to be overcome in viral gene therapy is the rejection of the
transforming virus by the immune system.
Phage therapy, the use of bacteriophages to combat bacterial diseases, was a popular research
topic before the advent of antibiotics and has recently seen renewed interest.
Oncolytic viruses are viruses that preferably infect cancer cells. While early efforts to employ
these viruses in the therapy of cancer failed, there have been reports in 2005 and 2006 of
encouraging preliminary results
History of Virology
A very early form of vaccination known as variolation was developed several thousand
years ago in China. It involved the application of materials from smallpox sufferers in order to
immunize others. In 1717 Lady Mary Wortley Montagu observed the practice in Istanbul and
attempted to popularize it in Britain, but encountered considerable resistance. In 1796 Edward
Jenner developed a much safer method, using cowpox to successfully immunize a young boy
against smallpox, and this practice was widely adopted. Vaccinations against other viral
diseases followed, including the successful rabies vaccination by Louis Pasteur in 1886. The
nature of viruses however was not clear to these researchers.
Virology
Martinus Beijerinck
The existence of viruses that infect bacteria (bacteriophages) was first recognized by Frederick
Twort in 1911, and, independently, by Felix d'Herelle in 1917. Since bacteria could be grown
easily in culture, this led to an explosion of virology research.
The cause of the devastating Spanish flu pandemic of 1918 was initially unclear. In late 1918,
French scientists showed that a "filter-passing virus" could transmit the disease to people and
animals, fulfilling Koch's postulates.
While plant viruses and bacteriophages can be grown comparatively easily, animal viruses
normally require a living host animal, which complicates their study immensely. In 1931 it was
shown that influenza virus could be grown in fertilized chicken eggs, a method that is still used
today to produce vaccines. In 1937, Max Theiler managed to grow the yellow fever virus in
chicken eggs and produced a vaccine from an attenuated virus strain; this vaccine saved
millions of lives and is still being used today.
Virology
Continuation...
Max Delbrück, an important investigator in the area of bacteriophages, described the basic life
cycle of a virus in 1937: rather than "growing", a virus particle is assembled from its constituent
pieces in one step; eventually it leaves the host cell to infect other cells. The Hershey-Chase
experiment in 1952 showed that only DNA and not protein enters a bacterial cell upon infection
with bacteriophage T2. Transduction of bacteria by bacteriophages was first described in the
same year.
In 1949 John F. Enders, Thomas Weller and Frederick Robbins reported that they had been able
to grow poliovirus in cultured human embryonal cells, the first significant example of an animal
virus grown outside of animals or chicken eggs. This work aided Jonas Salk in deriving a polio
vaccine from killed polio viruses; this vaccine was shown to be effective in 1955.
The first virus that could be crystalized and whose structure could therefore be elucidated in
detail was tobacco mosaic virus (TMV), the virus that had been studied earlier by Ivanovski and
Beijerink. In 1935, Wendell Stanley achieved its crystallization for electron microscopy and
showed that it remains active even after crystallization. Clear X-ray diffraction pictures of the
crystallized virus were obtained by Bernal and Fankuchen in 1941. Based on such pictures,
Rosalind Franklin proposed the full structure of the tobacco mosaic virus in 1955. Also in 1955,
Heinz Fraenkel-Conrat and Robley Williams showed that purified TMV RNA and its capsid (coat)
protein can assemble by themselves to form functional viruses, suggesting that this simple
mechanism is likely the natural assembly mechanism within the host cell, as Delbrück had
proposed earlier.
In 1963, the Hepatitis B virus was discovered by Baruch Blumberg who went on to develop a
vaccine against Hepatitis B.
In 1965, Howard Temin described the first retrovirus: an RNA-virus that was able to insert its
genome in the form of DNA into the host's genome. Reverse transcriptase, the key enzyme that
retroviruses use to translate their RNA into DNA, was first described in 1970, independently by
Howard Temin and David Baltimore. The first retrovirus infecting humans was identified by
Robert Gallo in 1974. Later it was found that reverse transcriptase is not specific to retroviruses;
retrotransposons which code for reverse transcriptase are abundant in the genomes of all
eukaryotes. About 10-40% of the human genome derives from such retrotransposons.
In 1975 the functioning of oncoviruses was clarified considerably. Until that time, it was thought
that these viruses carried certain genes called oncogenes which,
Virology
Continuation...
When inserted into the host's genome, would cause cancer. Michael Bishop and Harold Varmus
showed that the oncogene of Rous sarcoma virus is in fact not specific to the virus but is
contained in the genome of healthy animals of many species. The oncovirus can switch this pre-
existing benign proto-oncogene on, turning it into a true oncogene that causes cancer.
1976 saw the first recorded outbreak of Ebola hemorrhagic fever, a highly lethal virally
transmitted disease.
In 1977, Frederick Sanger achieved the first complete sequencing of the genome of any
organism, the bacteriophage Phi X 174. In the same year, Richard Roberts and Phillip Sharp
independently showed that the genes of adenovirus contain introns and therefore require gene
splicing. It was later realized that almost all genes of eukaryotes have introns as well.
A worldwide vaccination campaign led by the UN World Health Organization resulted in the
eradication of smallpox in 1979.
In 1982, Stanley Prusiner discovered prions and showed that they cause scrapie.
The first cases of AIDS were reported in 1981, and HIV, the retrovirus causing it, was identified
in 1983 by Robert Gallo and Luc Montagnier. Tests detecting HIV infection by detecting the
presence of HIV antibody were developed. Subsequent tremendous research efforts turned HIV
into the best studied virus. Human Herpes Virus 8, the cause of Kaposi's sarcoma which is often
seen in AIDS patients, was identified in 1994. Several antiretroviral drugs were developed in the
late 1990s, decreasing AIDS mortality dramatically in developed countries.
The Hepatitis C virus was identified using novel molecular cloning techniques in 1987, leading to
screening tests that dramatically reduced the incidence of post-transfusion hepatitis.
The first attempts at gene therapy involving viral vectors began in the early 1980s, when
retroviruses were developed that could insert a foreign gene into the host's genome. They
contained the foreign gene but did not contain the viral genome and therefore could not
reproduce. Tests in mice were followed by tests in humans, beginning in 1989. The first human
studies attempted to correct the genetic disease severe combined immunodeficiency (SCID),
but clinical success was limited. In the period from 1990 to 1995, gene therapy was tried on
several other diseases and with different viral vectors, but it became clear that the initially high
expectations were overstated. In 1999 a further setback occurred when 18-year-old Jesse
Gelsinger died in a gene therapy trial.
Virology
Continuation...
He suffered a severe immune response after having received an adenovirus vector. Success in
the gene therapy of two cases of X-linked SCID was reported in 2000.
In 2002 it was reported that poliovirus had been synthetically assembled in the laboratory,
representing the first synthetic organism. Assembling the 7741-base genome from scratch,
starting with the virus's published RNA sequence, took about two years. In 2003 a faster
method was shown to assemble the 5386-base genome of the bacteriophage Phi X 174 in 2
weeks.
The giant mimivirus, in some sense an intermediate between tiny prokaryotes and ordinary
viruses, was described in 2003 and sequenced in 2004.
The strain of Influenza A virus subtype H1N1 that killed up to 50 million people during the
Spanish flu pandemic in 1918 was reconstructed in 2005. Sequence information was pieced
together from preserved tissue samples of flu victims; viable virus was then synthesized from
this sequence. The 2009 flu pandemic involved another strain of Influenza A H1N1, commonly
known as "swine flu".
By 1985, Harald zur Hausen had shown that two strains of Human papillomavirus (HPV) cause
most cases of cervical cancer. Two vaccines protecting against these strains were released in
2006.
In 2006 and 2007 it was reported that introducing a small number of specific transcription
factor genes into normal skin cells of mice or humans can turn these cells into pluripotent stem
cells, known as Induced Pluripotent Stem Cells. The technique uses modified retroviruses to
transform the cells; this is a potential problem for human therapy since these viruses integrate
their genes at a random location in the host's genome, which can interrupt other genes and
potentially causes cancer.
Immunology
Introduction
A second line of defense is the specific or adaptive immune system which may take days to
respond to a primary invasion (that is infection by an organism that has not hitherto been
seen). In the specific immune system, we see the production of antibodies (soluble proteins
that bind to foreign antigens) and cell-mediated responses in which specific cells recognize
foreign pathogens and destroy them. In the case of viruses or tumors, this response is also vital
to the recognition and destruction of virally-infected or tumorigenic cells. The response to a
second round of infection is often more rapid than to the primary infection because of the
activation of memory B and T cells. We shall see how cells of the immune system interact with
one another by a variety of signal molecules so that a coordinated response may be mounted.
These signals may be proteins such as lymphokines which are produced by cells of the lymphoid
system, cytokines and chemokines that are produced by other cells in an immune response,
and which stimulate cells of the immune system.
Immunology
Continuation...
Immunology is a broad branch of biomedical science that covers the study of all aspects of the
immune system in all organisms. It deals with the physiological functioning of the immune
system in states of both health and disease; malfunctions of the immune system in
immunological disorders (autoimmune diseases, hypersensitivities, immune deficiency,
transplant rejection); the physical, chemical and physiological characteristics of the components
of the immune system in vitro, in situ, and in vivo. Immunology has applications in several
disciplines of science, and as such is further divided.
Even before the concept of immunity (from immunis, Latin for "exempt") was
developed, numerous early physicians characterized organs that would later prove to be part of
the immune system. The key primary lymphoid organs of the immune system are like thymus
and bone marrow, and secondary lymphatic tissues such as spleen, tonsils, lymph vessels,
lymph nodes, adenoids, and skin. When health conditions warrant, immune system organs
including the thymus, spleen, portions of bone marrow, lymph nodes and secondary lymphatic
tissues can be surgically excised for examination while patients are still alive.
Many components of the immune system are actually cellular in nature and not associated with
any specific organ but rather are embedded or circulating in various tissues located throughout
the body.
Immunology
Classical immunology
Classical immunology ties in with the fields of epidemiology and medicine. It studies the
relationship between the body systems, pathogens, and immunity. The earliest written mention
of immunity can be traced back to the plague of Athens in 430 BCE. Thucydides noted that
people who had recovered from a previous bout of the disease could nurse the sick without
contracting the illness a second time. Many other ancient societies have references to this
phenomenon, but it was not until the 19th and 20th centuries before the concept developed
into scientific theory.
The study of the molecular and cellular components that comprise the immune system,
including their function and interaction, is the central science of immunology. The immune
system has been divided into a more primitive innate immune system, and acquired or adaptive
immune system of vertebrates, the latter of which is further divided into humoral and cellular
components.
The humoral (antibody) response is defined as the interaction between antibodies and
antigens. Antibodies are specific proteins released from a certain class of immune cells (B
lymphocytes). Antigens are defined as anything that elicits generation of antibodies, hence they
are Antibody Generators. Immunology itself rests on an understanding of the properties of
these two biological entities. However, equally important is the cellular response, which can not
only kill infected cells in its own right, but is also crucial in controlling the antibody response.
Put simply, both systems are highly interdependent.
In the 21st century, immunology has broadened its horizons with much research being
performed in the more specialized niches of immunology. This includes the immunological
function of cells, organs and systems not normally associated with the immune system, as well
as the function of the immune system outside classical models of immunity (Yemeserach 2010).
Immunology
Developmental immunology
The body’s capability to react to antigen depends on a person's age, antigen type,
maternal factors and the area where the antigen is presented. Neonates are said to be in a
state of physiological immunodeficiency, because both their innate and adaptive immunological
responses are greatly suppressed. Once born, a child’s immune system responds favorably to
protein antigens while not as well to glycoproteins and polysaccharies. In fact, many of the
infections acquired by neonates are caused by low virulence organisms like Staphylococcus and
Pseudomonas. In neonates, opsonic activity and the ability to activate the complement cascade
is very limited. For example, the mean level of C3 in a newborn is approximately 65% of that
found in the adult. Phagocytic activity is also greatly impaired in newborns. This is due to lower
opsonic activity, as well as diminished up-regulation of integrin and selectin receptors, which
limit the ability of neutrophils to interact with adhesion molecules in the endothelium. Their
monocytes are slow and have a reduced ATP production, which also limits the newborns
phagocitic activity. Although, the number of total lymphocytes is significantly higher than in
adults, the cellular and humoral immunity is also impaired. Antigen presenting cells in
newborns have a reduced capability to activate T cells. Also, T cells of a newborn proliferate
poorly and produce very small amounts of cytokines like IL-2, IL-4, IL-5, IL-12, and IFN-g which
limits their capacity to activate the humoral response as well as the phagocitic activity of
macrophage. B cells develop early in gestation but are not fully active.
Maternal factors also play a role in the body’s immune response. At birth most of the
immunoglobulin is present is maternal IgG. Because IgM, IgD, IgE and IgA don’t cross the
placenta, they are almost undetectable at birth. Although some IgA is provided in breast milk.
These passively acquired antibodies can protect the newborn up to 18 months, but their
response is usually short-live and of low affinity. These antibodies can also produce a negative
response. If a child is exposed to the antibody for a particular antigen before being exposed to
the antigen itself then the child will produce a dampened response. Passively acquired maternal
antibodies can suppress the antibody response to active immunization. Similarly the response
of T-cells to vaccination differs in children compared to adults, and vaccines that induce Th1
responses in adults do not readily elicit these same responses in neonates. By 6-9 months after
birth, a child’s immune system begins to respond more strongly to glycoproteins. Not until 12-
24 months of age is there a marked improvement in the body’s response to polysaccharides.
This can be the reason for the specific time frames found in vaccination schedules.
Immunology
Continuation...
During adolescence the human body undergoes several physical, physiological and
immunological changes. These changes are started and mediated by different hormones.
Depending on the sex testosterone or 17-β-oestradiol, act on male and female bodies
accordingly; start acting at ages of 12 and 10 years. There is evidence that these steroids act
directly not only on the primary and secondary sexual characteristics, but also have an effect on
the development and regulation of the immune system. There is an increased risk in developing
autoimmunity for pubescent and post pubescent females and males. There is also some
evidence that cell surface receptors on B cells and macrophages may detect sex hormones in
the system. The female sex hormone 17-β-oestradiol has been shown to regulate the level of
immunological response. Similarly, some male androgens, like testosterone, seem to suppress
the stress response to infection; but other androgens like DHEA have the opposite effect, as it
increases the immune response instead of down playing it. As in females, the male sex
hormones seem to have more control of the immune system during puberty and the time right
after than in fully developed adults. Other than hormonal changes physical changes like the
involution of the Thymus during puberty will also affect the immunological response of the
subject or patient.
Immunotherapy
The use of immune system components to treat a disease or disorder is known as
immunotherapy. Immunotherapy is most commonly used in the context of the treatment of
cancers together with chemotherapy (drugs) and radiotherapy (radiation). However,
immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people
suffering from other immune deficiencies or autoimmune diseases.
Immunology
Diagnostic immunology
The specificity of the bond between antibody and antigen has made it an excellent tool
in the detection of substances in a variety of diagnostic techniques. Antibodies specific for a
desired antigen can be conjugated with a radiolabel, fluorescent label, or color-forming enzyme
and are used as a "probe" to detect it. However, the similarity between some antigens can lead
to false positives and other errors in such tests by antibodies cross-reacting with antigens that
aren't exact matches
Evolutionary immunology
Study of the immune system in extant and extinct species is capable of giving us a key
understanding of the evolution of species and the immune system.
A development of complexity of the immune system can be seen from simple phagocytotic
protection of single celled organisms, to circulating antimicrobial peptides in insects to
lymphoid organs in vertebrates. Of course, like much of evolutionary observation, these
physical properties are often seen from the anthropocentric aspect. It should be recognized
that every organism living today has an immune system absolutely capable of protecting it from
most forms of harm; those organisms that did not adapt their immune systems to external
threats are no longer around to be observed.
Insects and other arthropods, while not possessing true adaptive immunity, show highly
evolved systems of innate immunity, and are additionally protected from external injury (and
exposure to pathogens) by their chitinous shells.
Immunology
Reproductive immunology
Immunologist
According to the American Academy of Allergy, Asthma, and Immunology (AAAAI), "an
immunologist is a research scientist who investigates the immune system of vertebrates
(including the human immune system). Immunologists include research scientists (Ph.D.) who
work in laboratories. Immunologists also include physicians who, for example, treat patients
with immune system disorders. Some immunologists are physician-scientists who combine
laboratory research with patient care.
PARASITOLOGY
MYCOLOGY
VIROLOGY
IMMUNOLOGY
MICRO BIOLOGY (LEC)
(parasitology, mycology, virology, immunology)
Tecson, Roi Ace D.
DMD – 2B